Europe Inhalation Anesthesia Market Size, Share & Industry Trends Analysis Report By Drug (Sevoflurane, Desflurane, Isoflurane, and Others), By Application (Maintenance and Induction), By Country and Growth Forecast, 2022 - 2028

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Inhalation Anesthesia Market, by Drug
1.4.2 Europe Inhalation Anesthesia Market, by Application
1.4.3 Europe Inhalation Anesthesia Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Europe Inhalation Anesthesia Market by Drug
3.1 Europe Sevoflurane Market by Country
3.2 Europe Desflurane Market by Country
3.3 Europe Isoflurane Market by Country
3.4 Europe Others Market by Country

Chapter 4. Europe Inhalation Anesthesia Market by Application
4.1 Europe Maintenance Market by Country
4.2 Europe Induction Market by Country

Chapter 5. Europe Inhalation Anesthesia Market by Country
5.1 Germany Inhalation Anesthesia Market
5.1.1 Germany Inhalation Anesthesia Market by Drug
5.1.2 Germany Inhalation Anesthesia Market by Application
5.2 UK Inhalation Anesthesia Market
5.2.1 UK Inhalation Anesthesia Market by Drug
5.2.2 UK Inhalation Anesthesia Market by Application
5.3 France Inhalation Anesthesia Market
5.3.1 France Inhalation Anesthesia Market by Drug
5.3.2 France Inhalation Anesthesia Market by Application
5.4 Russia Inhalation Anesthesia Market
5.4.1 Russia Inhalation Anesthesia Market by Drug
5.4.2 Russia Inhalation Anesthesia Market by Application
5.5 Spain Inhalation Anesthesia Market
5.5.1 Spain Inhalation Anesthesia Market by Drug
5.5.2 Spain Inhalation Anesthesia Market by Application
5.6 Italy Inhalation Anesthesia Market
5.6.1 Italy Inhalation Anesthesia Market by Drug
5.6.2 Italy Inhalation Anesthesia Market by Application
5.7 Rest of Europe Inhalation Anesthesia Market
5.7.1 Rest of Europe Inhalation Anesthesia Market by Drug
5.7.2 Rest of Europe Inhalation Anesthesia Market by Application

Chapter 6. Company Profiles
6.1 Novartis AG
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Product Launches and Product Expansions:
6.2 Piramal Enterprises Limited
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Hikma Pharmaceuticals PLC
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expenses
6.4 Fresenius SE & Co. KGaA
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.5 Baxter International, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expense
6.5.5 Recent strategies and developments:
6.5.5.1 Partnerships, Collaborations, and Agreements:
6.5.5.2 Approvals and Trials:
6.6 AbbVie, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expense
6.7 Halocarbon Products Corporation
6.7.1 Company Overview
6.8 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
6.8.1 Company Overview
6.9 Lunan Pharmaceutical Group Co., Ltd.
6.9.1 Company Overview
6.10. Troikaa Pharmaceuticals Limited
6.10.1 Company Overview